History of CEO/Directors of St. Jude

Dr. Donald Pinkel

1961 - 1973

Dr. Donald Pinkel served as the first director and CEO of St. Jude Children’s Research Hospital, focusing on ALL, the most frequent cancer in young children, he and his colleagues identified four major obstacles to its cure: drug resistance, drug toxicity, meningeal relapse and most important, pessimism.

Learn more

Dr. Alvin Mauer

1973 - 1983

Dr. Alvin Mauer served as the second director and CEO of St. Jude. During his tenure as director, St. Jude doubled in size, adding a $10.5 million research building. Mauer established the hospital’s Affiliate Program, which created St. Jude clinics in other cities, enabling some children to receive their treatments closer to home rather than traveling to Memphis.

Learn more

Dr. Joseph Simone

1983 - 1992

Dr. Joseph Simone served as the third director and CEO of St. Jude. He joined the hospital in 1967 as a faculty physician. He chaired the Department of Hematology and served as associate director for Clinical Research. Simone brought scientific attention to St. Jude by entering the Pediatric Oncology Group in 1981 and later paved the way for St. Jude to be a charter member of the National Comprehensive Cancer Network.

Learn more

Dr. Arthur W. Nienhuis

1993 - 2004

Dr. Arthur W. Nienhuis served as fourth director and CEO of St. Jude. His research interests and expertise in bone marrow transplant, gene therapy and genetic testing paved the way for many advances, including breakthroughs in sickle cell disease and other hematological disorders. Under his leadership, the hospital completed a $1 billion expansion, which included the addition of a Children’s GMP, LLC facility.

Learn more

Dr. William E. Evans

2004 - 2014

Dr. William E. Evans served as the fifth director and CEO of St. Jude. Under his leadership, St. Jude expanded its research to include Chemical Biology and Therapeutics, Epidemiology and Cancer Control, and exploited new technologies to further understand the genomic basis of childhood cancers and to develop individualized approaches to cancer treatment.

Learn more

Dr. James R. Downing

2014 - present

Dr. James R. Downing is St. Jude Children’s Research Hospital’s sixth and current director and CEO. Downing’s work as a genome sequencing pioneer, overseeing the Pediatric Cancer Genome Project, was recognized in 2012 by TIME magazine as one of the Top 100 new scientific discoveries. 

Learn more